To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events (COAGFAII)

This study has been completed.
Sponsor:
Collaborator:
Ministry of Health, France
Information provided by:
Hopital Lariboisière
ClinicalTrials.gov Identifier:
NCT01224574
First received: September 13, 2010
Last updated: October 19, 2010
Last verified: September 2010
  Purpose

The primary aim of the study was to assess whether D-Dimer level at entry or an increase of D-Dimer level during the follow-up could predict the occurrence of subsequent cardiovascular events in patients with atrial fibrillation.


Condition
Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Place Des D-dimères Dans la Prise en Charge Des Patients en Fibrillation Auriculaire : Evaluation de la Valeur prédictive Des D-dimères Sur la Survenue d'événements Thromboemboliques

Resource links provided by NLM:


Further study details as provided by Hopital Lariboisière:

Biospecimen Retention:   Samples Without DNA

No biospecimens are to be retained


Enrollment: 425
Study Start Date: January 2001
Study Completion Date: July 2007
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Patients will be followed-up every 4 months with clinical assessment and D-dimer blinded measurement.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with atrial fibrillation encountered in usual care

Criteria

Inclusion Criteria:

  • atrial fibrillation

Exclusion Criteria:

  • follow-up not possible, poor prognosis within 3 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01224574

Locations
France
AP HP
Paris, France
Sponsors and Collaborators
Hopital Lariboisière
Ministry of Health, France
Investigators
Principal Investigator: Isabelle Mahé, MD,PhD Hopital Lariboisière
  More Information

Publications:
Responsible Party: Projet Hospitalier de Recherche Clinique Régional, Direction de la Recherche Clinique
ClinicalTrials.gov Identifier: NCT01224574     History of Changes
Other Study ID Numbers: AOR 01 029
Study First Received: September 13, 2010
Last Updated: October 19, 2010
Health Authority: France: Ministry of Health

Keywords provided by Hopital Lariboisière:
atrial fribrillation, cardiovascular events, aging, D-dimer

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on September 18, 2014